Monthly Archives: August 2023

Significant First Responder Biomarker Improvements Drive InsideTracker to Launch Custom Blood Test Panel

CAMBRIDGE, Mass., Aug. 30, 2023 /PRNewswire/ — InsideTracker, the leading personalized health analysis and data-driven wellness guide that helps people live healthier longer, announces the introduction of a new, customized blood testing panel specifically created to address the unique health challenges of first responders. Continue Reading First responders are consistently “less healthy” at the time […]

Comparative mortality rates of SARS-CoV-2 and influenza in France before and after the COVID-19 pandemic

In a recent study published in Epidemiology & Infection, researchers investigate the contribution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza to hospitalizations and mortality to inform future vaccination and treatment policies. Study: Mortality associated with Omicron and influenza infections in France before and during the COVID-19 pandemic. Image Credit: Luca9257 / Shutterstock.com […]

Dual acting drug delivers blood cancer a lethal ‘one-two’ punch in mice

Credit: Monash University Melbourne researchers have designed a single drug that delivers a lethal “one-two” punch to several types of blood cancer in preclinical studies and could lead to improved treatments. The collaboration between medicinal chemists, laboratory and clinician scientists at Monash University and Peter MacCallum Cancer Center developed a single drug that works like […]

Bempedoic Acid Proves Cardiovascular Benefit Across Glycemic Spectrum in New Analysis

Kausik Ray, MBChB, MDCredit: BAIM Institute Data from an analysis of the landmark CLEAR Outcomes trial suggests bempedoic acid could prove useful in the treatment algorithms for statin-intolerant patients with diabetes mellitus. Results of the study, which were presented at the European Society of Cardiology (ESC) Congress 2023, indicate use of bempedoic acid significantly reduced […]

RESVERLOGIX ANNOUNCES A FAVORABLE OUTLOOK BASED ON NEW CARDIOVASCULAR DISEASE TREATMENT GUIDELINES FOR PATIENTS WITH TYPE 2 DIABETES

AMSTERDAM – Resverlogix Corp. (‘Resverlogix’) (TSX: RVX) today announced that new guidelines published by the European Society of Cardiology (ESC) reflect unmet need in the reduction of cardiovascular risk in patients with type 2 diabetes, and highlight the opportunity for apabetalone to benefit this high-risk population. New emphasis on combining multiple drugs with proven cardiovascular […]

Data from Glycomine’s Ongoing Natural History Study Provides Insight into Clinical Measures and Biomarkers for PMM2-CDG

#inform-video-player-1 .inform-embed { margin-top: 10px; margin-bottom: 20px; } #inform-video-player-2 .inform-embed { margin-top: 10px; margin-bottom: 20px; } SAN CARLOS, Calif.–(BUSINESS WIRE)–Aug 30, 2023– Glycomine, Inc., a biotechnology company focused on developing new therapies for orphan diseases, announced the presentation of summary findings from its ongoing natural history study at the Society for the Study of Inborn […]

Heart disease: More than half of cases linked to poor lifestyle

More than half of all heart attacks and strokes are avoidable, a new global study has found. The Global Cardiovascular Risk Consortium – an international team, including scientists from six Australian research bodies – found that more than half of cardiovascular diseases worldwide are linked to five factors. All of these factors are a result […]

New Blood Test Detects a Key Indicator of Parkinson’s Disease

Researchers have developed a blood test that detects Parkinson’s disease, potentially establishing a way to help diagnose the condition before nervous system damage worsens. A new blood-based diagnostic test would be a major advancement for Parkinson’s disease, which afflicts 10 million people worldwide and is the second-most common neurodegenerative disease after Alzheimer’s. Led by a […]